Anti-Rituximab Antibodies in Primary Membranous Nephropathy: Time for Routine Monitoring in Clinical Practice?

6 , to the best of our knowledge is the largest to date to address this issue, showed a notable trend toward lower stringent immunological remission, as defined by anti-PLA2R levels < 2 AU/ml, at 6 and 12 months in ARA+ patients.

also in 2,380 other papers

The differences did not reach statistical significance, possibly because of insufficient included participants.

also in 111,027 other papers